Choroidal Anatomic Alterations After Photodynamic Therapy for Chronic Central Serous Chorioretinopathy: A Multicenter Study.
Central Serous Chorioretinopathy
/ diagnosis
Choroid
/ pathology
Chronic Disease
Fluorescein Angiography
Follow-Up Studies
Fundus Oculi
Humans
Macula Lutea
/ pathology
Photochemotherapy
/ methods
Photosensitizing Agents
/ therapeutic use
Retrospective Studies
Tomography, Optical Coherence
Treatment Outcome
Verteporfin
/ therapeutic use
Visual Acuity
Journal
American journal of ophthalmology
ISSN: 1879-1891
Titre abrégé: Am J Ophthalmol
Pays: United States
ID NLM: 0370500
Informations de publication
Date de publication:
09 2020
09 2020
Historique:
received:
08
12
2019
revised:
17
04
2020
accepted:
18
04
2020
pubmed:
4
5
2020
medline:
7
10
2020
entrez:
4
5
2020
Statut:
ppublish
Résumé
To study the early anatomic choroidal alterations in eyes with chronic central serous chorioretinopathy (CSCR) undergoing photodynamic therapy (PDT). Multicenter retrospective cohort study. A total of 77 patients and 81 eyes with chronic CSCR treated with PDT and 64 untreated fellow eyes were evaluated. Central macular thickness (CMT) and choroidal features including subfoveal choroidal thickness (SFCT), total choroidal area (TCA), luminal choroidal area (LCA), and stromal choroidal area (SCA) were analyzed. Choroidal vascularity index (CVI) was calculated in all study eyes at baseline and at 1- and 3-months post-PDT. In eyes receiving PDT, Snellen visual acuity (VA) significantly improved at months 1 and 3 (P < .001). CMT and SFCT showed a significant reduction from baseline at months 1 and 3 (P < .001), whereas TCA and LCA showed a significant decrease only at the 1-month follow-up visit. Baseline mean TCA and LCA were 2.30 ± 1.41 mm After PDT for chronic CSCR we observed sustained reductions in CMT and SFCT, while reductions in TCA and LCA were only noted at the 1-month follow-up interval. These choroidal parameters may provide additional quantitative biomarkers to evaluate the anatomic response to therapy but await further prospective validation.
Identifiants
pubmed: 32360342
pii: S0002-9394(20)30190-2
doi: 10.1016/j.ajo.2020.04.022
pii:
doi:
Substances chimiques
Photosensitizing Agents
0
Verteporfin
0X9PA28K43
Types de publication
Journal Article
Multicenter Study
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
104-113Informations de copyright
Copyright © 2020 Elsevier Inc. All rights reserved.